ascopubs.org

Comparison between nivolumab plus ipilimumab, FOLFOX and nivolumab plus FOLFOX therapy as first-line treatment for cisplatin-unfit advanced esophageal squamous cell carcinoma.

Three-year and five-year outcomes of a phase II study of perioperative CapeOx therapy for advanced gastric cancer with extensive lymph node metastasis (OGSG1701). Trifluridine/tipiracil and ...
ascopubs.org

Bold-100-001: A randomized phase 2 study of bold-100 plus FOLFOX vs FOLFOX in patients with refractory metastatic colorectal cancer.

METEORITE: A phase II study of Y-90, capecitabine, and atezolizumab in oligometastatic CRC (BrUOG430). This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...